Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
Status:
Recruiting
Trial end date:
2022-06-15
Target enrollment:
Participant gender:
Summary
This is an exploratory study designed to generate preliminary data in evaluating the efficacy
of Nucala in the treatment of chronic spontaneous urticaria.